232 related articles for article (PubMed ID: 35682973)
1. Neuroinflammation in Friedreich's Ataxia.
Apolloni S; Milani M; D'Ambrosi N
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682973
[TBL] [Abstract][Full Text] [Related]
2. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
[TBL] [Abstract][Full Text] [Related]
3. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia.
Hackett PT; Jia X; Li L; Ward DM
J Biol Chem; 2022 Jun; 298(6):101982. PubMed ID: 35472330
[TBL] [Abstract][Full Text] [Related]
5. An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia.
Turchi R; Faraonio R; Lettieri-Barbato D; Aquilano K
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33126466
[TBL] [Abstract][Full Text] [Related]
6. Altered lipid metabolism in a Drosophila model of Friedreich's ataxia.
Navarro JA; Ohmann E; Sanchez D; Botella JA; Liebisch G; Moltó MD; Ganfornina MD; Schmitz G; Schneuwly S
Hum Mol Genet; 2010 Jul; 19(14):2828-40. PubMed ID: 20460268
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
[TBL] [Abstract][Full Text] [Related]
8. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
Anzovino A; Lane DJ; Huang ML; Richardson DR
Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
Gomes CM; Santos R
Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
[TBL] [Abstract][Full Text] [Related]
10. GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich ataxia cellular models.
Dong YN; McMillan E; Clark EM; Lin H; Lynch DR
Hum Mol Genet; 2019 May; 28(10):1594-1607. PubMed ID: 30590615
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in friedreich's ataxia.
Lodi R; Taylor DJ; Schapira AH
Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
[TBL] [Abstract][Full Text] [Related]
12. Frataxin knockdown in human astrocytes triggers cell death and the release of factors that cause neuronal toxicity.
Loría F; Díaz-Nido J
Neurobiol Dis; 2015 Apr; 76():1-12. PubMed ID: 25554687
[TBL] [Abstract][Full Text] [Related]
13. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
[TBL] [Abstract][Full Text] [Related]
14. No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells.
Steinkellner H; Singh HN; Muckenthaler MU; Goldenberg H; Moganty RR; Scheiber-Mojdehkar B; Sturm B
Gene; 2017 Jul; 621():5-11. PubMed ID: 28412459
[TBL] [Abstract][Full Text] [Related]
15. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.
Tan G; Chen LS; Lonnerdal B; Gellera C; Taroni FA; Cortopassi GA
Hum Mol Genet; 2001 Sep; 10(19):2099-107. PubMed ID: 11590127
[TBL] [Abstract][Full Text] [Related]
16. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
[TBL] [Abstract][Full Text] [Related]
18. Friedreich's ataxia: past, present and future.
Marmolino D
Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidative stress in Friedreich's ataxia.
Lupoli F; Vannocci T; Longo G; Niccolai N; Pastore A
FEBS Lett; 2018 Mar; 592(5):718-727. PubMed ID: 29197070
[TBL] [Abstract][Full Text] [Related]
20. Friedreich's ataxia: the vicious circle hypothesis revisited.
Bayot A; Santos R; Camadro JM; Rustin P
BMC Med; 2011 Oct; 9():112. PubMed ID: 21985033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
